Safety Incidents OSHA Severe Injury Reports · 2015–2025
5,189,992Inspections Most recent open 2026-07-18 Last loaded 2026-07-22

OSHA Inspection: ASCENT PHARMACEUTICALS INC.

Referral inspection · Safety discipline

On , OSHA opened a referral safety inspection of ASCENT PHARMACEUTICALS INC. in 400 S.TECHNOLOGY DRIVE, CENTRAL ISLIP, NY 11749 (NAICS 325412). OSHA activity number 345813554.

What this inspection record means

OSHA opens inspections for many reasons — routine scheduling under a national or local emphasis program, an employee complaint or referral, or a follow-up after a reported injury. Opening or conducting an inspection is not itself an allegation or a finding that this employer broke any rule; any findings appear as the citations listed below, and citations can be contested, reduced, or withdrawn.

Watch Ascent Pharmaceuticals INC. — free Get an email when a new federal OSHA severe-injury report for Ascent Pharmaceuticals INC. is published. One employer, no account, unsubscribe in one click.
Site address
400 S.TECHNOLOGY DRIVE
City
CENTRAL ISLIP
State
NY
ZIP
11749
Mailing
400 S.TECHNOLOGY DRIVE, CENTRAL ISLIP, NY 11749
Inspection type
Referral (C)
Scope
Complete (A)
Discipline
Safety
Advance notice
No
Union status
B
Opened
Closing conference
Case closed
Last modified
Data loaded
NAICS code
325412
Employees
300
Ownership type
A

1 citation on file for this inspection.

1910.147 C04 II B

Serious Gravity 10 1 instance 1 exposed
Issued
Aug 30, 2022
Abate by
Sep 12, 2022
Penalty
Initial $14,502 · Current $8,700 Reduced
29 CFR  1910.147(c)(4)(ii)(B): The energy control procedures did not clearly and specifically outline the steps for shutting down, isolating, blocking and securing machines or equipment to control hazardous energy.   A) Workplace, Manufacturing Section- Employee was performing adjustment on a newly acquired Auto ODF Strip Packaging Machine. The employer's written energy control procedures, also known as the "written Lockout Tagout program" did not a include clear and specific outline for steps to shut down, isolate and secure the machine; on or about 3/1/22.  Note:  In addition to abatement certification the employer is required to submit abatement documentation for this item in accordance with 29 CFR 1903.19
Recent events (2)
  • — I (S) $8700
  • — Z (S) $14502

View Ascent Pharmaceuticals INC.'s full OSHA safety record →

This record is reproduced from the U.S. Department of Labor Open Data API (OSHA inspection dataset). The original IMIS detail view is available at OSHA's Establishment Search for activity number 345813554.

Look up any company's OSHA accident reports by company, or browse severe injury reports by year, state, and company.